Insulin resistance in patients with polycystic ovary syndrome

Ann Med. 2004;36(6):426-39. doi: 10.1080/07853890410035296.

Abstract

With a prevalence of 5%-10% the polycystic ovary syndrome (PCOS) is an exceptionally common disorder of premenopausal women. According to prospective studies, women with PCOS present abnormal glucose tolerance and diabetes mellitus in 31%-35% and 7.5%-10%, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension, type 2 diabetes and dyslipidaemia. The rate of spontaneous abortions as well as the risk to develop gestational or type 2 diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem but a complex endocrine disease with important health implications. The role of the glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.

Publication types

  • Review

MeSH terms

  • Blood Glucose / metabolism
  • Cardiovascular Diseases / physiopathology
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetes Mellitus, Type 2 / prevention & control
  • Diabetes Mellitus, Type 2 / therapy
  • Diet
  • Exercise
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance / genetics
  • Insulin Resistance / physiology*
  • Obesity / physiopathology
  • Polycystic Ovary Syndrome / genetics
  • Polycystic Ovary Syndrome / physiopathology*
  • Polycystic Ovary Syndrome / therapy
  • Pregnancy
  • Pregnancy Complications / physiopathology
  • Risk Factors

Substances

  • Blood Glucose
  • Hypoglycemic Agents